Healthcare of Ontario Pension Plan Trust Fund Has $20.74 Million Stake in Axon Enterprise, Inc $AXON

Healthcare of Ontario Pension Plan Trust Fund increased its position in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 42.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 36,525 shares of the biotechnology company’s stock after buying an additional 10,852 shares during the period. Healthcare of Ontario Pension Plan Trust Fund’s holdings in Axon Enterprise were worth $20,744,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. Creative Financial Designs Inc. ADV acquired a new position in Axon Enterprise during the fourth quarter worth $28,000. New Millennium Group LLC acquired a new position in Axon Enterprise during the third quarter worth $29,000. Sound Income Strategies LLC raised its position in shares of Axon Enterprise by 550.0% in the fourth quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock valued at $30,000 after purchasing an additional 44 shares during the period. Camelot Portfolios LLC bought a new position in shares of Axon Enterprise in the fourth quarter valued at about $30,000. Finally, AlphaCentric Advisors LLC bought a new position in shares of Axon Enterprise in the fourth quarter valued at about $34,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research firms recently commented on AXON. Citizens Jmp decreased their price target on shares of Axon Enterprise from $825.00 to $700.00 and set a “market outperform” rating on the stock in a research note on Thursday, May 7th. Citigroup restated a “buy” rating on shares of Axon Enterprise in a research note on Wednesday, February 25th. Morgan Stanley set a $600.00 price target on shares of Axon Enterprise in a research note on Thursday, May 7th. Craig Hallum restated a “buy” rating and issued a $820.00 price target on shares of Axon Enterprise in a research note on Wednesday, February 25th. Finally, Wall Street Zen upgraded shares of Axon Enterprise from a “sell” rating to a “hold” rating in a research note on Saturday, February 28th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $712.75.

Axon Enterprise Trading Up 0.3%

AXON opened at $443.21 on Tuesday. Axon Enterprise, Inc has a twelve month low of $339.01 and a twelve month high of $885.91. The company has a 50-day simple moving average of $410.95 and a 200 day simple moving average of $488.34. The company has a quick ratio of 1.93, a current ratio of 2.27 and a debt-to-equity ratio of 0.49. The stock has a market capitalization of $35.72 billion, a price-to-earnings ratio of 178.00, a P/E/G ratio of 8.03 and a beta of 1.45.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings data on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share for the quarter, topping the consensus estimate of $1.60 by $0.01. Axon Enterprise had a net margin of 6.90% and a return on equity of 3.78%. The business had revenue of $807.35 million during the quarter, compared to analysts’ expectations of $778.91 million. During the same quarter in the prior year, the business posted $1.47 earnings per share. Axon Enterprise’s revenue was up 33.7% compared to the same quarter last year. Analysts predict that Axon Enterprise, Inc will post 1.82 EPS for the current fiscal year.

Insider Buying and Selling at Axon Enterprise

In related news, CRO Cameron Brooks sold 1,242 shares of the company’s stock in a transaction dated Thursday, June 4th. The shares were sold at an average price of $500.00, for a total transaction of $621,000.00. Following the completion of the sale, the executive owned 49,710 shares of the company’s stock, valued at $24,855,000. This represents a 2.44% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Joshua Isner sold 13,000 shares of the company’s stock in a transaction dated Friday, June 5th. The stock was sold at an average price of $488.45, for a total transaction of $6,349,850.00. Following the sale, the president directly owned 169,125 shares of the company’s stock, valued at $82,609,106.25. This represents a 7.14% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 38,989 shares of company stock valued at $19,090,083 over the last three months. 4.20% of the stock is owned by insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.